Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2018 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2018 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells

Corrigendum in: /10.3892/mmr.2021.12283
  • Authors:
    • Sumiyasuren Buyanravjikh
    • Sora Han
    • Sunyi Lee
    • Ae Lee Jeong
    • Hye In Ka
    • Ji Young Park
    • Ariundavaa Boldbaatar
    • Jong‑Seok Lim
    • Myeong‑Sok Lee
    • Young Yang
  • View Affiliations / Copyright

    Affiliations: Department of Biological Science, Sookmyung Women's University, Seoul 04310, Republic of Korea
  • Pages: 1095-1103
    |
    Published online on: May 22, 2018
       https://doi.org/10.3892/mmr.2018.9042
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Atopic dermatitis (AD) is a type of chronic skin inflammation and one of the most common relapsing allergic diseases, which presents with a severe rash and itchy skin lesions. The pathogenesis of AD is primarily associated with hyper‑activated mast cells, which makes them an effective treatment target. After cross‑linking the antigen/immunoglobulin (Ig) E complex binds to its high affinity receptor FcεRl on the surface of mast cells. The cells subsequently secrete excessive pro‑inflammatory mediators, including histamine and cytokines, which lead to pruritus and immune cell infiltration in the skin lesions. The present study screened natural compounds that have an inhibitory effect on IgE/antigen‑mediated secretory activity. It was revealed that cryptotanshinone (CRT), a natural compound extracted from Salvia miltiorrhiza Bunge, had inhibitory effects on the IgE/antigen complex. The underlying mechanism by which CRT exerted an anti‑allergy/inflammatory function was investigated using rat basophilic leukaemia (RBL) cells for degranulation assays and a 1‑chloro‑2,4‑dinitrobenzene (DNCB)‑induced AD Balb/c mouse model for in vivo study. CRT effectively mitigated the secretion of pro‑inflammatory cytokines, including tumor necrosis factor‑α and interleukin 1β, as well as immune cell infiltration into skin lesions in a mouse model of AD‑like skin disease induced by dinitrochlorobenzene. The inhibitory effect of CRT on IgE‑mediated mast cell degranulation was mediated by the inhibition of tyrosine kinase‑dependent degranulation signalling pathways involving spleen tyrosine kinase and Lyn. The present study revealed CRT as an inhibitor of mast cell degranulation. Therefore, CRT may be considered for development as a therapeutic drug to treat IgE‑mediated skin diseases.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Park S, Lee JB and Kang S: Topical application of Chrysanthemum indicum L. attenuates the development of atopic dermatitis-like skin lesions by suppressing serum IgE levels, IFN-γ, and IL-4 in Nc/Nga mice. Evid Based Complement Alternat Med. 2012:8219672012. View Article : Google Scholar : PubMed/NCBI

2 

Kim SR, Choi HS, Seo HS, Ku JM, Hong SH, Yoo HH, Shin YC and Ko SG: Oral administration of herbal mixture extract inhibits 2,4-dinitrochlobenzene-induced atopic dermatitis in BALB/c mice. Mediators Inflamm. 2014:3194382014. View Article : Google Scholar : PubMed/NCBI

3 

Martel BC, Lovato P, Bäumer W and Olivry T: Translational animal models of atopic dermatitis for preclinical studies. Yale J Biol Med. 90:389–402. 2017.PubMed/NCBI

4 

Lee KS, Jeong ES, Heo SH, Seo JH, Jeong DG and Choi YK: A novel model for human atopic dermatitis: Application of repeated DNCB patch in BALB/c mice, in comparison with NC/Nga mice. Lab Anim Res. 26:95–102. 2010. View Article : Google Scholar

5 

Kim SR, Choi HS, Seo HS, Choi YK, Shin YC and Ko SG: Topical application of herbal mixture extract inhibits ovalbumin- or 2,4-dinitrochlorobenzene-induced atopic dermatitis. Evid Based Complement Alternat Med. 2012:5454972012. View Article : Google Scholar : PubMed/NCBI

6 

Shim J, Kennedy RH, Weatherly LM, Hutchinson LM, Pelletier JH, Hashmi HN, Blais K, Velez A and Gosse JA: Arsenic inhibits mast cell degranulation via suppression of early tyrosine phosphorylation events. J Appl Toxicol. 36:1446–1459. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Suzuki K and Verma IM: Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation. Cell. 134:485–495. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Hepp R, Puri N, Hohenstein AC, Crawford GL, Whiteheart SW and Roche PA: Phosphorylation of SNAP-23 regulates exocytosis from mast cells. J Biol Chem. 280:6610–6620. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Park JH, Lee B, Kim HK, Kim EY, Kim JH, Min JH, Kim S, Sohn Y and Jung HS: Peimine inhibits the production of proinflammatory cytokines through regulation of the phosphorylation of NF-κB and MAPKs in HMC-1 cells. Pharmacogn Mag. 13 Suppl 2:S359–S364. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Lian Q, Cheng Y, Zhong C and Wang F: Inhibition of the IgE-mediated activation of RBL-2H3 cells by TIPP, a novel thymic immunosuppressive pentapeptide. Int J Mol Sci. 16:2252–2268. 2015. View Article : Google Scholar : PubMed/NCBI

11 

Choi HS and Kim KM: Tanshinones inhibit mast cell degranulation by interfering with IgE receptor-mediated tyrosine phosphorylation of PLCgamma2 and MAPK. Planta Med. 70:178–180. 2004. View Article : Google Scholar : PubMed/NCBI

12 

Wang BQ: Salvia miltiorrhiza: Chemical and pharmacological review of medicinal plant. J Med Plants Res. 4:pp2813–2820. 2010.

13 

Gao H, Sun W, Zhao J, Wu X, Lu JJ, Chen X, Xu QM, Khan IA and Yang S: Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from Salvia miltiorrhiza Bunge (Danshen). Sci Rep. 6:337202016. View Article : Google Scholar : PubMed/NCBI

14 

Liu B, Du Y, Cong L, Jia X and Yang G: Danshen (Salvia miltiorrhiza) compounds improve the biochemical indices of the patients with coronary heart disease. Evid Based Complement Alternat Med. 2016:97817152016. View Article : Google Scholar : PubMed/NCBI

15 

Chen W and Chen G: Danshen (Salvia miltiorrhiza Bunge): A prospective healing sage for cardiovascular diseases. Curr Pharm Des. 23:5125–5135. 2017.PubMed/NCBI

16 

Shin DS, Kim HN, Shin KD, Yoon YJ, Kim SJ, Han DC and Kwon BM: Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. Cancer Res. 69:193–202. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Passante E and Frankish N: The RBL-2H3 cell line: Its provenance and suitability as a model for the mast cell. Inflamm Res. 58:737–745. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Metzger H, Alcaraz G, Hohman R, Kinet JP, Pribluda V and Quarto R: The receptor with high affinity for immunoglobulin E. Annu Rev Immunol. 4:419–470. 1986. View Article : Google Scholar : PubMed/NCBI

19 

Seldin DC, Adelman S, Austen KF, Stevens RL, Hein A, Caulfield JP and Woodbury RG: Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proc Natl Acad Sci USA. 82:3871–3875. 1985. View Article : Google Scholar : PubMed/NCBI

20 

Bantz SK, Zhu Z and Zheng T: The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 5:pii: 202. 2014.PubMed/NCBI

21 

Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DY, Lipozencic J, et al: Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 118:152–169. 2006. View Article : Google Scholar : PubMed/NCBI

22 

Ku JM, Hong SH, Kim HI, SEo HS, Shin YC and Ko SG: Effects of Angelicae dahuricae Radix on 2, 4-Dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice model. BMC Complement Altern Med. 17:982017. View Article : Google Scholar : PubMed/NCBI

23 

Lawrence T: The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 1:a0016512009. View Article : Google Scholar : PubMed/NCBI

24 

Junghans V, Gutgesell C, Jung T and Neumann C: Epidermal cytokines IL-1beta, TNF-alpha, and IL-12 in patients with atopic dermatitis: Response to application of house dust mite antigens. J Invest Dermatol. 111:1184–1188. 1998. View Article : Google Scholar : PubMed/NCBI

25 

Lin G, Gao S, Cheng J, Li Y, Shan L and Hu Z: 1β-hydroxyalantolactone, a sesquiterpene lactone from Inula japonica, attenuates atopic dermatitis-like skin lesions induced by 2,4-dinitrochlorobenzene in the mouse. Pharm Biol. 54:516–522. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Pokharel YR, Lim SC, Kim SC, Heo TH, Choi HK and Kang HK: Sopungyangjae-tang inhibits development of dermatitis in Nc/Nga mice. Evid Based Complement Alternat Med. 5:173–180. 2008. View Article : Google Scholar : PubMed/NCBI

27 

Gao D, Mendoza A, Lu S and Lawrence DA: Immunomodulatory effects of Danshen (Salvia miltiorrhiza) in BALB/c mice. ISRN Inflamm. 2012:9540322012. View Article : Google Scholar : PubMed/NCBI

28 

Stone KD, Prussin C and Metcalfe DD: IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 125 2 Suppl 2:S73–S80. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Kawakami Y, Kitaura J, Satterthwaite AB, Kato RM, Asai K, Hartman SE, Maeda-Yamamoto M, Lowell CA, Rawlings DJ, Witte ON and Kawakami T: Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J Immunol. 165:1210–1219. 2000. View Article : Google Scholar : PubMed/NCBI

30 

Lee M, Lee NY, Chung KS, Cheon SY, Lee KT and An HJ: Roxatidine attenuates mast cell-mediated allergic inflammation via inhibition of NF-κB and p38 MAPK activation. Sci Rep. 7:417212017. View Article : Google Scholar : PubMed/NCBI

31 

Chen W, Lui L, Luo Y, Odaka Y, Awate S, Zhou H, Shen T, Zheng S, Lu Y and Huang S: Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells. Cancer Prev Res (Phila). 5:778–787. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Kim JH, Jeong SJ, Kwon TR, Yun SM, Jung JH, Kim M, Lee HJ, Lee MH, Ko SG, Chen CY and Kim SH: Cryptotanshinone enhances TNF-α-induced apoptosis in chronic myeloid leukemia KBM-5 cells. Apoptosis. 16:696–707. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Suh SJ, Jin UH, Choi HJ, Chang HW, Son JK, Lee SH, Jeon SJ, Son KH, Chang YC, Lee YC and Kim CH: Cryptotanshinone from Salvia miltiorrhiza BUNGE has an inhibitory effect on TNF-alpha-induced matrix metalloproteinase-9 production and HASMC migration via down-regulated NF-kappaB and AP-1. Biochem Pharmacol. 72:1680–1689. 2006. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Buyanravjikh S, Han S, Lee S, Jeong AL, Ka HI, Park JY, Boldbaatar A, Lim JS, Lee MS, Yang Y, Yang Y, et al: Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells Corrigendum in /10.3892/mmr.2021.12283. Mol Med Rep 18: 1095-1103, 2018.
APA
Buyanravjikh, S., Han, S., Lee, S., Jeong, A.L., Ka, H.I., Park, J.Y. ... Yang, Y. (2018). Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells Corrigendum in /10.3892/mmr.2021.12283. Molecular Medicine Reports, 18, 1095-1103. https://doi.org/10.3892/mmr.2018.9042
MLA
Buyanravjikh, S., Han, S., Lee, S., Jeong, A. L., Ka, H. I., Park, J. Y., Boldbaatar, A., Lim, J., Lee, M., Yang, Y."Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells Corrigendum in /10.3892/mmr.2021.12283". Molecular Medicine Reports 18.1 (2018): 1095-1103.
Chicago
Buyanravjikh, S., Han, S., Lee, S., Jeong, A. L., Ka, H. I., Park, J. Y., Boldbaatar, A., Lim, J., Lee, M., Yang, Y."Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells Corrigendum in /10.3892/mmr.2021.12283". Molecular Medicine Reports 18, no. 1 (2018): 1095-1103. https://doi.org/10.3892/mmr.2018.9042
Copy and paste a formatted citation
x
Spandidos Publications style
Buyanravjikh S, Han S, Lee S, Jeong AL, Ka HI, Park JY, Boldbaatar A, Lim JS, Lee MS, Yang Y, Yang Y, et al: Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells Corrigendum in /10.3892/mmr.2021.12283. Mol Med Rep 18: 1095-1103, 2018.
APA
Buyanravjikh, S., Han, S., Lee, S., Jeong, A.L., Ka, H.I., Park, J.Y. ... Yang, Y. (2018). Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells Corrigendum in /10.3892/mmr.2021.12283. Molecular Medicine Reports, 18, 1095-1103. https://doi.org/10.3892/mmr.2018.9042
MLA
Buyanravjikh, S., Han, S., Lee, S., Jeong, A. L., Ka, H. I., Park, J. Y., Boldbaatar, A., Lim, J., Lee, M., Yang, Y."Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells Corrigendum in /10.3892/mmr.2021.12283". Molecular Medicine Reports 18.1 (2018): 1095-1103.
Chicago
Buyanravjikh, S., Han, S., Lee, S., Jeong, A. L., Ka, H. I., Park, J. Y., Boldbaatar, A., Lim, J., Lee, M., Yang, Y."Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells Corrigendum in /10.3892/mmr.2021.12283". Molecular Medicine Reports 18, no. 1 (2018): 1095-1103. https://doi.org/10.3892/mmr.2018.9042
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team